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Group A rotaviruses are important infectious agents of diarrhea in many mammalian and avian species. 6, 25 Bovine rotavirus (BRV) serotypes are a major cause of diarrhea in calves 1-3 weeks of age 13, 16, 25 and are classified by the detection of neutralizing antibodies directed against 2 outer capsid proteins, VP4 (88 kD) and VP7 (37 kD) 6,10 The VP7 is the major serotypic antigen and is referred to as the G type (for glycoprotein), whereas VP4 is referred to as the P type (for protease sensitivity). 6 At least 14 G types and 12 P types have been identified among group A rotaviruses. 6,10,21 Traditional serotyping assays, such as plaque-reduction virus neutralization (PRVN) test and fluorescent focus neutralization (FFN) test, mainly detect neutralizing antibodies to VP7. 6, 25 Less information is available for serotyping on the basis of the VP4 protein. 6 The PRVN and FFN assays are laborious and are often difficult to interpret because of the dual serotype specificity of rotaviruses. Therefore, there is a need for specific and sensitive methods of serotyping rotaviruses. Several methods developed for the G typing of rotaviruses include the polymerase chain reaction, cDNA probes for hybridization assays, and the use of monoclonal antibodies (MAbs) in the enzyme-linked immunosorbent assay (ELISA). 2, 5, 6, 8, 10, 12, 15, 1619, 23 Epidemiologic studies have identified G6 and G10 as the most frequent VP7 serotypes in cattle in the USA and other countries. 12, 15, 20 Few reports have been published about other G serotypes of BRV. 11, 12, 15 Investigators have described G1, G2, G3, G8, and G11 types among field BRV strains. 3, 4, 11, 12, 15, 20 Recently, investigators working with humans have recovered group A rotavirus strains with G6 9 and G10 1 specificity; these types are normally associated with the bovine population. These studies indicate that bovine G types may circulate among the human population and vice versa. Field specimens from geographically diverse regions of North America need to be tested to determine the prevalence of human G types, such as G1, G2, and G3.
The objective of the present study was to develop an ELISA for the routine typing of rotavirus G1, G2, and G3 types in group A BRV-positive samples and to use it to test a large number of field samples from North America. For this study, 159 group A rotavirus-positive bovine fecal samples previously determined to be negative for G6 and G10 serotypes by ELISA were analyzed. 12 These samples were collected between 1988 and 1994 from diarrheic calves from Ohio, Michigan, South Dakota, Nebraska, and California and from Canada and have been previously described. 11, 12, 15 Known BRV-negative fecal samples from uninfected gnotobiotic calves were used as negative controls. 12 The samples were tested for group A rotavirus using the following techniques: ELISA, 13 immune electron microscopy (IEM), 17 polyacrylamide gel electrophoresis (PAGE), 26 and cell culture immunoflourescence. 24 Several rotavirus strains were used as reference controls to define the specificity of the MAbs. Human rotaviruses used were Wa and M37 (G1), DS-1 and 1076 (G2), M (G3), VA70 (G4), and 69M (G8). Animal rotaviruses were also used: simian, SA11 and RRV; porcine, Gottfried (G4) and OSU (G5); equine, HI (G5); bovine, NCDV Lincoln and IND (G6), and B223 and Cr (G10). These viruses were propagated in MA-104 cells as described previously 18 and had titers of 10 4 -10 8 fluorescent focus units (FFU)/ml. Some of the BRVpositive strains were passaged in gnotobiotic or colostrumdeprived calves, and the fecal specimens obtained from these animals were also used in the ELISA.
Three neutralizing MAbs, 5E8 (G1 specific), IC10 (G2 specific), and 4F8 (G3 specific), directed against rotavirus VP7 were used. a The presence of VP7 in the samples was detected using a nonneutralizing broadly reactive VP7 MAb, Common 60. a Ascites produced from SP2/0 myeloma cells Table 2 . Mean absorbance* (690 nm) for serotyping ELISA using reference rotavirus strains and known negative samples. Table 1 . Fluorescent focus neutralization titers* of the G1, G2, and G3 serotype-specific monoclonal antibodies (MAbs) against reference G serotypes of human and animal group A rotaviruses, was used as a negative coating. Cell culture fluid from hybridomas or ascites fluid was purified using an Avid-Al affinity column. b The neutralizing activity of the MAbs was determined by FFN tests as previously described. 12 The neutralizing antibody titer was expressed as the reciprocal of the highest dilution of the MAb that reduced the number of FFUs by 60% or more. The reactivity of the MAbs (G1, G2, G3) in the FFN test with various cell culture-adapted rotavirus strains (human and animal) is shown in Table 1 . The MAb 5E8 neutralized G1 serotypes represented by the M37 and Wa strains of human rotavirus but did not neutralize the other strains belonging to heterologous serotypes. The MAb 1C10 neutralized the human rotaviruses DS-1 and 1076, representing serotype G2, but did not neutralize other rotavirus G serotypes. The MAb 4F8 neutralized the animal strains RRV, SA11 and human rotavirus M strain, all belonging to G3, but failed to neutralize other rotavirus G serotypes ( Table 1) .
The ELISA procedure was adapted from previously described methods. 12 Optimal dilutions of reagents were determined by checkerboard titration. Microtiter plate c wells were coated with 100 µ1 of purified hybridoma supernatants or ascites fluid containing MAbs specific for G1, G2, or G3 (concentrations ranging from 2 to 5 µg) diluted in carbonatebicarbonate buffer (pH 9.6). After incubation at 4 C overnight, the plates were washed 4 times with phosphate-buffered saline (PBS) (pH 7.4) containing 0.05% Tween 20 and 0.5 mM calcium chloride (PBS-T-CaCl 2 ). Following the wash, 200 µ1 of 10% nonfat dry milk in PBS-T-CaCl 2 was added as a blocking agent. The plates were incubated at 37 C for 2 hours. The plates were then washed, and 100 µ1 of the test fecal samples diluted 1:25 in PBS-T-CaC1 2 was added in duplicate. Appropriate positive and negative controls were also included (Table 2) , and the plates were incubated at 4 C overnight. The plates were again washed 4 times, and 100 µ1 of secondary antibody (anti-NCDV strain BRV serum from guinea pigs) was added at a 1:2,000 dilution. The plates were incubated at 37 C for 1 hour and then washed. Finally, 100 µ1 of conjugate (sheep anti-guinea pig IgG peroxidase) was added, and the plates were incubated for 1 hour at 37 C. The plates were then washed, and 100 µ1 of 2,2'-azinodi-3-ethylbenzthiazolene sulfonic acid containing citric acid and a 1:1,000 dilution of 30% H 2 O 2 was added. The reaction was stopped with 5% sodium dodecyl sulfate. The absorbance was measured at 690 nm using a multiscan spectrophotometer d interfaced to a computer. The samples were considered positive when the absorbance values were greater than the calculated cutoff value. The cutoff value was determined by calculating the mean absorbance value of the test fecal samples on the negative coating (SP2/0 ascites) and the control samples on the positive (G type MAb) and negative coating plus 3 SD.
The MAbs used were specific and reacted only with their respective G types in the MAb ELISA (Table 2) . MAb 5E8 reacted with human rotavirus strains M37 and Wa (G1). MAb 1C10 reacted with DS-1 and 1076 strains (G2), and MAb 4F8 reacted with strains RRV, SA11, and M (G3). The 3 MAbs had no reaction with rotaviruses of heterologous G serotypes or with the negative controls. All rotavirus samples had a positive reaction with the MAb Common 60 (Table  2) . Of 159 field group A rotavirus strains that were negative for serotype G6 and G10, 6 were typed as serotype G1, 1 was typed as serotype G2, and 2 showed reactivity with both G1 and G3 MAbs in ELISA (Table 3) . These 9 G1, G2, or G3 samples represented 5.26% of the total samples tested and originated from South Dakota and Ohio (Table 3) .
We developed a serotyping ELISA using G1-, G2-, and G3-specific MAbs and used it for testing field strains of BRV. All these strains had been previously shown to be group A rotavirus positive by ELISA, PAGE, or IEM but were confirmed as G6 and G10 negative in an MAb ELISA. 12 Some of these samples were also tested previously using G-typespecific cDNA probes. 11,15 At least 7 G serotypes of group A BRV have been identified using serologic or molecular methods (G1, G2, G3, G6, G8, G10, G11). [2] [3] [4] 11, 12, 15, 20, 27 Serotypes G6 and G10 have been considered the predominant G types in cattle. 12, 15, 20 In a study in 1990, a G1 BRV was reported from Argentina. 3 Recent studies in our laboratory have demonstrated the presence of serotypes G1 (n = 7), G2 (n = 1), G3 (n = 2), and G11 (n = 3) among 59 field BRV strains tested using cDNA probes. 11 The results of our present study indicate the presence of antigenically related rotavirus serotypes G1, G2, and G3 among the field BRV strains tested and confirm the existence of G serotypes other than G6 and G10 in the bovine population in North America. These samples were not previously tested in our study using G1-, G2-, and G3-specific cDNA probes. 11,15 However, using the G1 partial length cDNA probe, 3 G1-positive strains have been recently identified (Parwani et al., unpublished data) , but these strains tested negative by the G1-specific MAb ELISA. The reason for this discrepancy is not clear. One possible explanation is that G-specific MAbs are not able to detect monotypes (antigenic variants).** In this study, only a single MAb was used for each of the serotypes. The use of a pool of specific MAbs may increase the sensitivity of the serotyping ELISA for the serologic classification of field samples, as was done in an earlier study. 12 In some samples, the outer capsids may have degraded or disintegrated, as can occur during prolonged storage under conditions that are not optimal or as a result of frequent thawing. 7 In this study, all specimens were tested with the Common 60 MAb, which is directed to VP7 and recognizes Table 3 . Results of the analysis of bovine rotavirus field fecal specimens with G-serotype-specific monoclonal antibodies (G1, G2, G3) in ELISA. multiple rotavirus G serotypes. 12 Only 5 samples tested negative with the Common 60 MAb as well as with other G-specific MAbs.
The specificity observed for each of the MAbs with human and animal rotaviruses from cell culture in the serotyping ELISA corresponded to their determined specificities in the FFN test. There was no difference in the reactivity of human or animal strains (belonging to the same G type) with the MAbs. However, some specimens may have given false-negative results. Possible antigenic variation within serotypes (monotypes) among BRV strains could lead to their being unrecognized by the MAbs used. 23 The presence of 2 BRV strains with more than 1 serotype may be the result of a mixed infection with 2 rotaviruses or may be due to the existence of a dual VP7 serotype specificity, similar to that observed among porcine rotaviruses. 14 However, additional experiments are needed to fully evaluate this situation.
These BRV strains of serotypes G1, G2, and G3 may be natural reassortants between human and animal rotaviruses or may be naturally occurring animal strains. Prior to this study, there have been no reports of the antigenic investigation of human G serotypes in the bovine population in North America. The present study confirms and complements a previous study in which the existence of G1, G2, and G3 BRV strains was investigated using genomic typing with cDNA probes in hybridization assays. 11 Use of serotype-specific MAbs in the ELISA is a rapid and specific method for the G serotyping of BRV fecal samples and facilitates the analysis of a large number of samples. It provides an alternative method for the serologic classification of BRV strains. The discovery of G1, G2, and G3 strains demonstrates the serotypic diversity and complex antigenic relationships among human and animal rotavirus strains. The presence in animals of these strains with human G serotypes has important implications for medical researchers in terms of the Zoonotic potential of rotaviruses. It is necessary to continue these investigations to further characterize these and additional field strains of BRV. Knowledge of the diversity of rotavirus serotypes is fundamental for the development of efficacious vaccines.
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